DrugPatentWatch Database Preview
Investigational Drug Information for GS-0976
Email this page to a colleague
What is the development status for investigational drug GS-0976?
GS-0976 is an investigational drug.
There have been 7 clinical trials for GS-0976.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 8th 2016.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Gilead Sciences, Novo Nordisk A/S, and Nimbus Apollo.
There are five US patents protecting this investigational drug and one hundred and one international patents.
Summary for GS-0976
| US Patents | 5 |
| International Patents | 101 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 15 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-08-08) |
| Vendors | 26 |
Recent Clinical Trials for GS-0976
| Title | Sponsor | Phase |
|---|---|---|
| Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) | Novo Nordisk A/S | Phase 2 |
| Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) | Gilead Sciences | Phase 2 |
| Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) | Novo Nordisk A/S | Phase 2 |
Clinical Trial Summary for GS-0976
Top disease conditions for GS-0976
Top clinical trial sponsors for GS-0976
US Patents for GS-0976
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| GS-0976 | ⤷ Sign up for a Free Trial | Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof | Gilead Apollo, LLC (Foster City, CA) | ⤷ Sign up for a Free Trial |
| GS-0976 | ⤷ Sign up for a Free Trial | ACC inhibitors and uses thereof | Gilead Apollo, LLC (Foster City, CA) | ⤷ Sign up for a Free Trial |
| GS-0976 | ⤷ Sign up for a Free Trial | Processes for preparing ACC inhibitors and solid forms thereof | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Sign up for a Free Trial |
| GS-0976 | ⤷ Sign up for a Free Trial | ACC inhibitors and uses thereof | Nimbus Apollo, Inc. (Cambridge, MA) | ⤷ Sign up for a Free Trial |
| GS-0976 | ⤷ Sign up for a Free Trial | ACC inhibitors and uses thereof | Gilead Apollo, LLC (Foster City, CA) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for GS-0976
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| GS-0976 | Argentina | AR107790 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| GS-0976 | Australia | AU2017226267 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| GS-0976 | Brazil | BR112018067408 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| GS-0976 | Canada | CA3015526 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| GS-0976 | China | CN108699078 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| GS-0976 | China | CN112920200 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| GS-0976 | Eurasian Patent Organization | EA201891692 | 2036-03-02 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
